Pinnow Cole 4
4 · Cogent Biosciences, Inc. · Filed Jan 15, 2025
Insider Transaction Report
Form 4
Pinnow Cole
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2025-01-14$7.60/sh+43,750$332,413→ 45,848 total
Footnotes (2)
- [F1]The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $7.53 to $7.60. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
- [F2]Includes an aggregate of 1,398 shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on December 31, 2024.